The firm said that it plans to list its stock on the Nasdaq under ticker symbol "RAIN" and added that its 2014 revenues were up 78 percent year over year to $30.6 million.
The new assay expands a portfolio of viral load monitoring tests for the Cobas 6800 and 8800 systems.
The assay is intended for early infant diagnosis of HIV infection.
The results suggest AR-V7-postive patients should be treated with chemotherapy over AR-directed hormonal therapies to which they are highly resistant.
The company is offering about 3.6 million shares of its common stock, and warrants to purchase 715,000 shares of its stock.
In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.
With a new collection, PLOS highlights negative results it has published.
A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.
The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.